Trial Profile
Phase II trial of BRACAnalysis in metastatic triple negative breast cancer patients to identify which patients would respond to carboplatin or docetaxel
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Jul 2015
Price :
$35
*
At a glance
- Drugs Olaparib (Primary) ; Carboplatin; Docetaxel
- Indications Advanced breast cancer
- Focus Diagnostic use
- 24 Jul 2015 New trial record